Literature DB >> 34151523

Novel therapeutics for hydrocephalus: Insights from animal models.

Chuansen Wang1,2,3, Xiaoqiang Wang4, Changwu Tan1,2,3, Yuchang Wang1,2,3, Zhi Tang5, Zhiping Zhang1,2,3, Jingping Liu1,2,3, Gelei Xiao1,2,3.   

Abstract

Hydrocephalus is a cerebrospinal fluid physiological disorder that causes ventricular dilation with normal or high intracranial pressure. The current regular treatment for hydrocephalus is cerebrospinal fluid shunting, which is frequently related to failure and complications. Meanwhile, considering that the current nonsurgical treatments of hydrocephalus can only relieve the symptoms but cannot eliminate this complication caused by primary brain injuries, the exploration of more effective therapies has become the focus for many researchers. In this article, the current research status and progress of nonsurgical treatment in animal models of hydrocephalus are reviewed to provide new orientations for animal research and clinical practice.
© 2021 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  animal models; cerebrospinal fluid; hydrocephalus; nonsurgical treatment; subarachnoid space

Year:  2021        PMID: 34151523     DOI: 10.1111/cns.13695

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  6 in total

1.  Group-based trajectory modeling of intracranial pressure in patients with acute brain injury: Results from multi-center ICUs, 2008-2019.

Authors:  Fan Yang; Chi Peng; Liwei Peng; Peng Wang; Chao Cheng; Wei Zuo; Lei Zhao; Zhichao Jin; Weixin Li
Journal:  CNS Neurosci Ther       Date:  2022-05-25       Impact factor: 7.035

Review 2.  Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus.

Authors:  Yijian Yang; Jian He; Yuchang Wang; Chuansen Wang; Changwu Tan; Junbo Liao; Lei Tong; Gelei Xiao
Journal:  J Neuroinflammation       Date:  2022-06-17       Impact factor: 9.587

3.  Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response.

Authors:  Efstratios-Stylianos Pyrgelis; George P Paraskevas; Vasilios C Constantinides; Fotini Boufidou; Georgios Velonakis; Leonidas Stefanis; Elisabeth Kapaki
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

4.  A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.

Authors:  Harun Muayad Said; Derya Kaya; Idil Yavuz; Fatma Sena Dost; Zekiye Sultan Altun; Ahmet Turan Isik
Journal:  Clin Interv Aging       Date:  2022-04-11       Impact factor: 3.829

Review 5.  Ependymal Cilia: Physiology and Role in Hydrocephalus.

Authors:  Weiye Ji; Zhi Tang; Yibing Chen; Chuansen Wang; Changwu Tan; Junbo Liao; Lei Tong; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-07-12       Impact factor: 6.261

Review 6.  The pathogenesis of idiopathic normal pressure hydrocephalus based on the understanding of AQP1 and AQP4.

Authors:  Zitong Zhao; Jian He; Yibing Chen; Yuchang Wang; Chuansen Wang; Changwu Tan; Junbo Liao; Gelei Xiao
Journal:  Front Mol Neurosci       Date:  2022-09-20       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.